Igor Cavalcanti’s UFC journey has hit a major snag before it began.
The middleweight earned a UFC contract with a first-round knockout of Oscar Ravello on the September 15 episode of Dana White’s Contender Series. The Nevada Athletic Commission has now confirmed that “Jacare” tested positive for 19-Norandrosterone.
Cavalcanti is suspended until a final ruling in his case. It has not been confirmed whether the knockout will be overturned or what other penalties he could face.
Igor Cavalcanti’s Camp Responds
Manager Lucas Lutkus told MMA Fighting that Cavalcanti “had previously disclosed his nandrolone use to the UFC,” and said it was for medical purposes. He expanded on that in a statement.
Igor’s previous nandrolone use was part of a medical treatment following a right knee injury involving a medial meniscus tear and cartilage damage. According to his physician’s medical report, he received three intramuscular injections of 25 mg between February 21 and March 7, 2026, to support muscle recovery and knee stability.
At the time, Igor was preparing for a fight in Europe and had no knowledge that he would be competing in the UFC approximately six months later.
It is important to emphasize that Igor had previously disclosed his nandrolone use to the UFC and made no attempt to conceal the treatment. All In Sports Management began representing Igor in June 2026, after the treatment had concluded.
Since becoming aware of the situation, we have worked closely with Igor and his medical team to gather the relevant documentation and remain fully committed to transparency and cooperation throughout the process.